Business Context and Reporting Period
Chimera Investment Corporation filed a Form 8-K Current Report on January 28, 2011. The filing discloses the entry into a material definitive agreement regarding the potential sale of common stock.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a corporate action regarding equity distribution.
Material Changes
On January 28, 2011, the Company entered into an Equity Distribution Agreement with its manager, Fixed Income Discount Advisory Company (FIDAC), and UBS Securities LLC (UBS). Under this agreement:
- The Company may sell up to 125,000,000 shares of its common stock (par value $0.01 per share).
- Sales will be conducted through UBS as the sales agent via ordinary brokers' transactions on the New York Stock Exchange at market prices.
- The shares will be issued pursuant to an existing shelf registration statement on Form S-3 (File No. 333-159468) effective since May 26, 2009.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the terms of the distribution agreement. The agreement allows for sales "from time to time," indicating flexibility in execution timing and volume.
Key Facts for Investor Verification
- Verify the current market price of Chimera Investment Corporation common stock to assess potential dilution impact.
- Confirm the total number of authorized but unissued shares available under the existing Form S-3 registration statement.
- Monitor future filings for actual sales volumes and proceeds generated under the Equity Distribution Agreement.
- Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific termination clauses or minimum sale thresholds.